COST-EFFECTIVENESS OF INTERFERON-FREE THERAPY FOR HEPATITIS C IN GERMANY - AN APPLICATION OF THE EFFICIENCY FRONTIER APPROACH

被引:0
|
作者
Gissel, C. [1 ,2 ]
Goetz, G. [1 ]
Mahlich, J. [3 ]
Repp, H. [2 ]
机构
[1] Univ Giessen, Econ Ind Org Regulat & Antitrust 1, D-35390 Giessen, Germany
[2] Univ Giessen, Gen Med, D-35390 Giessen, Germany
[3] Janssen Cilag GmbH, Neuss, Germany
关键词
D O I
10.1016/S0168-8278(15)30921-1
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
P0718
引用
收藏
页码:S593 / S593
页数:1
相关论文
共 50 条
  • [21] Medical economics - Hepatitis C virus infection and cost-effectiveness of interferon therapy
    Inoue, Y
    HEPATOLOGY RESEARCH, 2002, 24 : S57 - S67
  • [22] Cost-effectiveness of interferon treatment for hepatitis C - Reply
    Wong, JB
    Koff, RS
    Pauker, SG
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 281 (22): : 2084 - 2084
  • [23] Hepatitis C Virus Epidemiology and the Impact of Interferon-Free Hepatitis C Virus Therapy
    Lazarus, Jeffrey, V
    Roel, Elena
    Elsharkawy, Ahmed M.
    COLD SPRING HARBOR PERSPECTIVES IN MEDICINE, 2020, 10 (03):
  • [24] Therapy of hepatitis C: Cost-effectiveness analysis
    Koff, RS
    HEPATOLOGY, 1997, 26 (03) : S152 - S155
  • [25] Role of ribavirin in interferon-free therapy for the treatment of hepatitis C virus
    Maria Morillas, Rosa
    Masnou, Helena
    Ardevol, Merce
    Lopez, Dulce
    GASTROENTEROLOGIA Y HEPATOLOGIA, 2017, 40 (10): : 699 - 708
  • [26] Body Composition Analysis after Interferon-Free Therapy for Hepatitis C
    Honda, Koichi
    Seike, Masataka
    Saito, Tomoko
    Iwao, Masao
    Tokoro, Masanori
    Arakawa, Mie
    Endo, Mizuki
    Oribe, Junya
    Murakami, Kazunari
    HEPATOLOGY, 2018, 68 : 938A - 939A
  • [27] Interferon-free therapy of hepatitis C with/without nucleoside polymerase inhibitor
    Lange, C. M.
    Sarrazin, C.
    Zeuzem, S.
    GASTROENTEROLOGE, 2015, 10 (04): : 292 - 296
  • [28] Interferon-free therapy for hepatitis C: The hurdles amid a golden era
    Colombo, Massimo
    DIGESTIVE AND LIVER DISEASE, 2015, 47 (09) : 727 - 733
  • [29] The Beginning of the End for Interferon Therapy? - Novel Interferon-free Treatment Options for Hepatitis C
    Zimmermann, H. W.
    Tacke, F.
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2014, 52 (05): : 450 - 452
  • [30] Cost-effectiveness and budget impact of interferon-free direct-acting antiviral-based regimens for hepatitis C treatment: the French case
    Deuffic-Burban, S.
    Obach, D.
    Canva, V.
    Pol, S.
    Roudot-Thoraval, F.
    Dhumeaux, D.
    Mathurin, P.
    Yazdanpanah, Y.
    JOURNAL OF VIRAL HEPATITIS, 2016, 23 (10) : 767 - 779